Anbio Biotechnology (NNNN) Total Liabilities (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Total Liabilities of $87836.0 for Q4 2025, down 94.92% year-over-year from $1.7 million in Q4 2024, and down 100.0% quarter-over-quarter from $131.1 billion in Q2 2025.
Anbio Biotechnology (NNNN) Total Liabilities (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Total Liabilities for 3 consecutive years, with $87836.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Liabilities fell 94.92% year-over-year to $87836.0; the TTM figure through Dec 2025 stood at $87836.0 (down 94.92% YoY), while the FY2025 annual figure was $87836.0, down 94.92% from the prior year.
- Total Liabilities slipped to $87836.0 in Q4 2025 per NNNN's latest filing, from $131.1 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $131.1 billion in Q2 2025 and bottomed at $87836.0 in Q4 2025.
- Historically, Total Liabilities has averaged $32.8 billion across 3 years, with a median of $1.4 million in 2023.
- Annual changes were most pronounced in 2024 — Total Liabilities soared 74.23% — and 2025, when it sank 94.92%.
- Anbio Biotechnology's Total Liabilities stood at $993060.0 in 2023, then jumped by 74.23% to $1.7 million in 2024, then tumbled by 94.92% to $87836.0 in 2025.
- Business Quant data shows NNNN's Total Liabilities at $87836.0 in Q4 2025, $131.1 billion in Q2 2025, and $1.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.05 Bn | 128.83 Bn | 1.96 Bn | 2.58 Bn |
| 2 | Becton Dickinson | 52.50 Bn | 51.64 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.70 Bn | 34.34 Bn | 1.68 Bn | 9.50 Bn |
| 4 | Resmed | 33.66 Bn | 32.19 Bn | 861.22 Mn | 2.38 Bn |
| 5 | Medline | 29.16 Bn | 26.49 Bn | 2.22 Bn | 20.27 Bn |
| 6 | West Pharmaceutical Services | 24.98 Bn | 24.54 Bn | 329.20 Mn | 1.09 Bn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | 9.44 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 4.24 Bn |
| 9 | Baxter International | 13.50 Bn | 11.35 Bn | 1.03 Bn | 13.61 Bn |
| 10 | Anbio Biotechnology | 298.28 Mn | 286.38 Mn | - | 87,836.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 87,836.00 |
| Jun 30, 2025 | 131.13 Bn |
| Dec 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 993,060.00 |